Logo image of AEGN

Aegion Corp (AEGN) Stock Fundamental Analysis

NASDAQ:AEGN - Nasdaq -

29.99  -0.01 (-0.03%)

After market: 29.95 -0.04 (-0.13%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to AEGN. AEGN was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of AEGN have multiple concerns. AEGN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AEGN had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -3.31%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -0.54%
PM (TTM) -3.24%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

3

2. Health

2.1 Basic Checks

AEGN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

AEGN has an Altman-Z score of 2.91. This is not the best score and indicates that AEGN is in the grey zone with still only limited risk for bankruptcy at the moment.
AEGN has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Altman-Z 2.91
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 2.14 indicates that AEGN has no problem at all paying its short term obligations.
A Quick Ratio of 1.92 indicates that AEGN should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 1.92

More info and screens

1

3. Growth

3.1 Past

AEGN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.31%.
The Earnings Per Share has been decreasing by -3.88% on average over the past years.
AEGN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.88%.
Measured over the past years, AEGN shows a decrease in Revenue. The Revenue has been decreasing by -9.54% on average per year.
EPS 1Y (TTM)-21.31%
EPS 3YN/A
EPS 5Y-3.88%
EPS Q2Q%33.33%
Revenue 1Y (TTM)-25.88%
Revenue growth 3YN/A
Revenue growth 5Y-9.54%
Sales Q2Q%-36.95%

3.2 Future

AEGN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.67% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y7.62%
EPS Next 2Y8.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AEGN Yearly Revenue VS EstimatesAEGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
AEGN Yearly EPS VS EstimatesAEGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 31.24, AEGN can be considered very expensive at the moment.
When comparing the Price/Earnings ratio of AEGN to the average of the S&P500 Index (24.95), we can say AEGN is valued slightly more expensively.
A Price/Forward Earnings ratio of 24.19 indicates a rather expensive valuation of AEGN.
The average S&P500 Price/Forward Earnings ratio is at 20.99. AEGN is around the same levels.
Industry RankSector Rank
PE 31.24
Fwd PE 24.19
AEGN Price Earnings VS Forward Price EarningsAEGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 47.77
AEGN Per share dataAEGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AEGN does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4.1
PEG (5Y)N/A
EPS Next 2Y8.67%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AEGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Aegion Corp

NASDAQ:AEGN (5/14/2021, 8:21:15 PM)

After market: 29.95 -0.04 (-0.13%)

29.99

-0.01 (-0.03%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)03-09 2022-03-09/dmh
Inst Owners0%
Inst Owner Change0%
Ins Owners1.83%
Ins Owner Change0%
Market Cap922.49M
Analysts60
Price Target29.92 (-0.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 31.24
Fwd PE 24.19
P/S 1.02
P/FCF N/A
P/OCF N/A
P/B 2.25
P/tB N/A
EV/EBITDA 47.77
EPS(TTM)0.96
EY3.2%
EPS(NY)1.24
Fwd EY4.13%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS29.5
BVpS13.32
TBVpSN/A
PEG (NY)4.1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.31%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -0.54%
PM (TTM) -3.24%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.14
Quick Ratio 1.92
Altman-Z 2.91
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.31%
EPS 3YN/A
EPS 5Y-3.88%
EPS Q2Q%33.33%
EPS Next Y7.62%
EPS Next 2Y8.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.88%
Revenue growth 3YN/A
Revenue growth 5Y-9.54%
Sales Q2Q%-36.95%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A